Nanobiotix annual total assets
2019
2020
2021
2022
2023
2024
2025
Nanobiotix Total Assets Growth & History (NANO)
Nanobiotix's total assets was €67.8M for fiscal 2025.
View full Nanobiotix company overviewNanobiotix annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €67.8M | €342,000 | +0.51% |
| 2024 | 2024-12-31 | €67.4M | −€26.5M | −28.20% |
| 2023 | 2023-12-31 | €93.9M | €34.1M | +57.10% |
| 2022 | 2022-12-31 | €59.8M | −€42.0M | −41.27% |
| 2021 | 2021-12-31 | €101.8M | −€32.3M | −24.07% |
| 2020 | 2020-12-31 | €134.0M | €77.8M | +138.47% |
| 2019 | 2019-12-31 | €56.2M | — | — |
Nanobiotix quarterly total assets
Q4.19
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | €67.8M | €342,000 | +0.51% |
| Q2 2025 | 2025-06-30 | €45.2M | −€41.5M | −47.88% |
| Q4 2024 | 2024-12-31 | €67.4M | −€26.5M | −28.20% |
| Q2 2024 | 2024-06-30 | €86.7M | €46.3M | +114.52% |
| Q4 2023 | 2023-12-31 | €93.9M | €34.1M | +57.10% |
| Q2 2023 | 2023-06-30 | €40.4M | −€40.2M | −49.88% |
| Q4 2022 | 2022-12-31 | €59.8M | −€42.0M | −41.27% |
| Q2 2022 | 2022-06-30 | €80.6M | −€43.3M | −34.94% |
| Q4 2021 | 2021-12-31 | €101.8M | −€32.3M | −24.07% |
| Q2 2021 | 2021-06-30 | €123.9M | — | — |
| Q4 2020 | 2020-12-31 | €134.0M | €77.8M | +138.47% |
| Q4 2019 | 2019-12-31 | €56.2M | — | — |
Nanobiotix total assets trends
Over the last five fiscal years, Nanobiotix's total assets decreased from €134.0M to €67.8M, a change of −€66.3M. The latest reported quarter, Q4 2025, shows €67.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗